Related Experiment Video
Updated: Jul 14, 2026

Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to
Jennifer L Whitwell1, Scott A Przybelski, Stephen D Weigand
1Department of Radiology, Mayo Clinic, 200 1st St SW, Rochester, MN 55905, USA.
Abstract:
Mild cognitive impairment (MCI), particularly the amnestic subtype (aMCI), is considered as a transitional stage between normal aging and a diagnosis of clinically probable Alzheimer's disease (AD). The aMCI construct is particularly useful as it provides an opportunity to assess a clinical stage which in most subjects represents prodromal AD. The aim of this study was to assess the progression of cerebral atrophy over multiple serial MRI during the period from aMCI to progression to AD. Thirty-three subjects were selected that fulfilled clinical criteria for aMCI and had three serial MRI scans: the first scan approximately 3 years before the diagnosis of AD, the second scan approximately 1 year before, and the third scan at the time of the diagnosis of AD. A group of 33 healthy controls were age and gender-matched to the study cohort. Voxel-based morphometry (VBM) was used to assess patterns of grey matter atrophy in the aMCI subjects at each time-point compared to the control group. Customized templates and prior probability maps were used to avoid normalization and segmentation bias. The pattern of grey matter loss in the aMCI subject scans that were 3 years before the diagnosis of AD was focused primarily on the medial temporal lobes, including the amygdala, anterior hippocampus and entorhinal cortex, with some additional involvement of the fusiform gyrus, compared to controls. The extent and magnitude of the cerebral atrophy further progressed by the time the subjects were 1 year before the diagnosis of AD. At this point atrophy in the temporal lobes spread to include the middle temporal gyrus, and extended into more posterior regions of the temporal lobe to include the entire extent of the hippocampus. The parietal lobe also started to become involved. By the time the subjects had progressed to a clinical diagnosis of AD the pattern of grey matter atrophy had become still more widespread with more severe involvement of the medial temporal lobes and the temporoparietal association cortices and, for the first time, substantial involvement of the frontal lobes. This pattern of progression fits well with the Braak and Braak neurofibrillary pathological staging scheme in AD. It suggests that the earliest changes occur in the anterior medial temporal lobe and fusiform gyrus, and that these changes occur at least 3 years before progression to the diagnosis of AD. These results also suggest that 3D patterns of grey matter atrophy may help to predict the time to the first diagnosis of AD in subjects with aMCI.
Insights
Mild cognitive impairment (MCI) shows early brain atrophy in medial temporal lobes at least 3 years before Alzheimer's disease (AD) diagnosis. This grey matter loss progresses over time, potentially predicting AD onset in aMCI patients.
Area of Science:
- Neuroscience
- Radiology
Background:
- Mild cognitive impairment (MCI), especially amnestic MCI (aMCI), is a transitional stage to Alzheimer's disease (AD).
- Understanding the progression of brain changes in aMCI is crucial for early detection and intervention in prodromal AD.
Purpose of the Study:
- To assess the progression of cerebral atrophy in individuals with aMCI over time, from the aMCI stage to the diagnosis of AD.
- To correlate patterns of grey matter loss with the Braak and Braak staging of AD pathology.
Main Methods:
- Longitudinal study of 33 aMCI subjects with three serial MRI scans (approx. 3 years before AD, 1 year before AD, and at AD diagnosis).
- Comparison with 33 age- and gender-matched healthy controls.
- Voxel-based morphometry (VBM) used to analyze grey matter atrophy patterns, employing customized templates to minimize bias.
Main Results:
- At least 3 years before AD diagnosis, aMCI subjects showed grey matter loss primarily in medial temporal lobes (amygdala, hippocampus, entorhinal cortex) and fusiform gyrus.
- By 1 year before AD diagnosis, atrophy extended to middle temporal gyrus, posterior hippocampus, and involved the parietal lobe.
- At AD diagnosis, atrophy was widespread, affecting medial temporal lobes, temporoparietal association cortices, and frontal lobes, consistent with Braak staging.
Conclusions:
- Grey matter atrophy in aMCI begins in the medial temporal lobe and fusiform gyrus at least 3 years prior to clinical AD diagnosis.
- The observed pattern and progression of atrophy align with the Braak and Braak pathological staging of AD.
- Serial MRI-based 3D grey matter atrophy patterns may serve as a predictive marker for the time to AD diagnosis in aMCI subjects.
Related Concept Videos
Dementia l: Introduction
Alzheimer Disease ll: Pathophysiology
Alzheimer Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia
The progression of dementia is generally gradual.

